tradingkey.logo

BRIEF-Bioage Labs Announces Company Updates On APJ, NLRP3, And Platform Programs

ReutersJan 28, 2025 2:07 PM

- BIOAGE Labs Inc BIOA.O:

  • BIOAGE LABS ANNOUNCES COMPANY UPDATES ON APJ, NLRP3, AND PLATFORM PROGRAMS

  • BIOAGE LABS: NOMINATION OF NLRP3 INHIBITOR BGE-102 AS A DEVELOPMENT CANDIDATE, WITH INITIAL PH1 CLINICAL DATA ANTICIPATED BY END OF 2025

Source text: ID:nGNX4tHV5V

Further company coverage: BIOA.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI